Related Experiment Videos
Computerized nuclear morphometry: a new morphologic assessment for advanced gastric adenocarcinoma
1Department of Surgery I, Faculty of Medicine, Tottori University, Yonago, Japan.
Annals of Surgery
|January 29, 1999
Summary
Large nuclear area in advanced gastric cancer indicates higher invasion potential and poorer survival. Nuclear morphometry offers a new way to predict metastasis in gastric adenocarcinoma.
Area of Science:
- Oncology
- Pathology
- Medical Imaging
Background:
- Nuclear profiles are established prognostic predictors in various cancers.
- Computerized morphometry offers objective and rapid analysis of nuclear features.
- Limited research exists on image analysis of nuclear features in gastric adenocarcinoma and their influencing biologic factors.
Purpose of the Study:
- To evaluate the correlation between morphologic nuclear features and clinicopathologic parameters in advanced gastric cancer.
- To determine if nuclear morphometry can predict metastatic potential and patient survival.
Main Methods:
- Analyzed morphometric nuclear features (area, perimeter, shape) in 202 patients with stage II/III gastric cancer.
- Utilized a computer-assisted image analysis system on hematoxylin and eosin-stained slides.
- Correlated morphometric data with patient survival, clinicopathologic status, DNA ploidy, p53 expression, and proliferation (Ki-67).
Main Results:
- Large nuclear areas correlated with lymph node metastasis, lymphatic invasion, and venous invasion.
- Significant correlations found between nuclear area and p53 expression, Ki-67 index, and DNA ploidy.
- Patients with large nuclear areas had significantly lower 5-year survival rates (47.6% vs. 74.4%).
- Nuclear area emerged as an independent prognostic factor in multivariate analysis.
Conclusions:
- Gastric cancer cells with large nuclear areas exhibit mutated p53 and high proliferative activity.
- These cells demonstrate a greater potential for microvessel invasion.
- Nuclear morphometry is a novel and valuable predictor of metastatic potential in advanced gastric cancer.